Wong F - Search Results

1

Innovative approaches to the management of ascites in cirrhosis.

Wong F. Wong F. JHEP Rep. 2023 Apr 5;5(7):100749. doi: 10.1016/j.jhepr.2023.100749. eCollection 2023 Jul. JHEP Rep. 2023. PMID: 37250493 Free PMC article. Review.

2

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.

Wong F, Gines P, Watson H, Horsmans Y, Angeli P, Gow P, Minini P, Bernardi M. Wong F, et al. J Hepatol. 2010 Aug;53(2):283-90. doi: 10.1016/j.jhep.2010.02.036. Epub 2010 May 24. J Hepatol. 2010. PMID: 20541828 Clinical Trial.

3

Medical management of ascites.

Leung W, Wong F. Leung W, et al. Among authors: wong f. Expert Opin Pharmacother. 2011 Jun;12(8):1269-83. doi: 10.1517/14656566.2011.549126. Epub 2011 Feb 10. Expert Opin Pharmacother. 2011. PMID: 21306283 Review.

4

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.

Wong F, Watson H, Gerbes A, Vilstrup H, Badalamenti S, Bernardi M, Ginès P; Satavaptan Investigators Group. Wong F, et al. Gut. 2012 Jan;61(1):108-16. doi: 10.1136/gutjnl-2011-300157. Epub 2011 Aug 11. Gut. 2012. PMID: 21836029 Clinical Trial.

5

Management of ascites in cirrhosis.

Wong F. Wong F. J Gastroenterol Hepatol. 2012 Jan;27(1):11-20. doi: 10.1111/j.1440-1746.2011.06925.x. J Gastroenterol Hepatol. 2012. PMID: 21916992 Review.

6

Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.

Tan HK, James PD, Sniderman KW, Wong F. Tan HK, et al. Among authors: wong f. J Gastroenterol Hepatol. 2015 Feb;30(2):389-95. doi: 10.1111/jgh.12725. J Gastroenterol Hepatol. 2015. PMID: 25168607

7

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G. Angeli P, et al. Among authors: wong f. J Hepatol. 2015 Apr;62(4):968-74. doi: 10.1016/j.jhep.2014.12.029. Epub 2015 Jan 28. J Hepatol. 2015. PMID: 25638527 Free article. No abstract available.

8

Refractory Ascites in Liver Cirrhosis.

Adebayo D, Neong SF, Wong F. Adebayo D, et al. Among authors: wong f. Am J Gastroenterol. 2019 Jan;114(1):40-47. doi: 10.1038/s41395-018-0185-6. Am J Gastroenterol. 2019. PMID: 29973706 Review.

9

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.

Neong SF, Adebayo D, Wong F. Neong SF, et al. Among authors: wong f. Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):293-305. doi: 10.1080/17474124.2018.1555469. Epub 2018 Dec 12. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791777 Review.

10

Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and Ascites.

Wong F, Reddy KR, Tandon P, O'Leary JG, Garcia-Tsao G, Vargas HE, Lai JC, Biggins SW, Maliakkal B, Fallon M, Subramanian R, Thuluvath P, Kamath PS, Thacker L, Bajaj JS. Wong F, et al. Clin Gastroenterol Hepatol. 2021 Aug;19(8):1661-1669.e2. doi: 10.1016/j.cgh.2020.08.025. Epub 2020 Aug 13. Clin Gastroenterol Hepatol. 2021. PMID: 32798707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,452 results

Search Page